Lv4
689 积分 2023-07-13 加入
Cell–cell communication inference and analysis in the tumour microenvironments from single-cell transcriptomics: data resources and computational strategies
17小时前
已完结
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors
17小时前
已完结
Post-COVID-19 condition symptoms among emergency department patients tested for SARS-CoV-2 infection
9天前
已关闭
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial
9天前
已完结
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
9天前
已完结
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
9天前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
9天前
已完结
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
9天前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
9天前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
9天前
已完结
皖公网安备34019202002308
